| Date | Time | Source | Headline | Symbol | Company |
| 06/14/2011 | 6:15AM | Zacks | Theravance Remains Neutral - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 06/13/2011 | 5:16PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/13/2011 | 1:47PM | Dow Jones News | UPDATE: Forest Labs Discloses Icahn Attempt At Board Shakeup | NYSE:FRX | Forest Road Acquisition Corp |
| 06/13/2011 | 9:30AM | PR Newswire (US) | Zacks' Voice of the People Highlights Opportunities With Forest Laboratories, AvalonBay and SunOpta | NYSE:FRX | Forest Road Acquisition Corp |
| 06/13/2011 | 8:51AM | Dow Jones News | Forest Labs: Icahn Nominates Four To Board, Holds 6.5% Stake | NYSE:FRX | Forest Road Acquisition Corp |
| 06/13/2011 | 7:30AM | Business Wire | Forest Laboratories Receives Notice of Director Nominations | NYSE:FRX | Forest Road Acquisition Corp |
| 06/10/2011 | 12:22PM | Zacks | Yep, Another 'I Told You So' - Voice of the People | NYSE:FRX | Forest Road Acquisition Corp |
| 06/10/2011 | 11:32AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/10/2011 | 8:36AM | Zacks | Update on Forest's Daliresp - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 06/09/2011 | 6:18PM | Business Wire | Forest Laboratories, Inc. Announces Availability of Daliresp™ in Pharmacies | NYSE:FRX | Forest Road Acquisition Corp |
| 06/09/2011 | 12:06PM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/08/2011 | 3:43PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/08/2011 | 3:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 06/07/2011 | 8:39AM | PR Newswire (US) | Court Certifies Overtime Class Action Against Forest Labs, According to The Ottinger Firm, P.C. | NYSE:FRX | Forest Road Acquisition Corp |
| 06/03/2011 | 10:16AM | Business Wire | Forest Laboratories, Inc. Announces Accelerated Share Repurchase | NYSE:FRX | Forest Road Acquisition Corp |
| 05/27/2011 | 6:00AM | Edgar (US Regulatory) | Annual Report (10-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/25/2011 | 12:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/19/2011 | 11:00AM | Zacks | Sanofi Ties Up With Glenmark - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 05/13/2011 | 12:43PM | Zacks | Forest to Present COPD Data - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 05/09/2011 | 5:29PM | Dow Jones News | Forest Labs Receives Subpoena Related To Hypertension Treatments | NYSE:FRX | Forest Road Acquisition Corp |
| 05/09/2011 | 4:07PM | Business Wire | Forest Laboratories, Inc. Receives Subpoena on Benicar®, Benicar HCT® and Azor® | NYSE:FRX | Forest Road Acquisition Corp |
| 05/09/2011 | 12:00PM | Business Wire | Forest and Almirall to Present Data from Phase III Studies of Aclidinium Bromide in Chronic Obstructive Pulmonary Disease (COPD) | NYSE:FRX | Forest Road Acquisition Corp |
| 05/09/2011 | 7:30AM | Marketwired | (NASDAQ: VTUS) Receives a Higher Price Estimate From Analysts | NYSE:FRX | Forest Road Acquisition Corp |
| 05/04/2011 | 8:00AM | Business Wire | Ironwood & Forest to Present Linaclotide Results from Phase 3 Trials in Patients with Irritable Bowel Syndrome with Constipation | NYSE:FRX | Forest Road Acquisition Corp |
| 04/20/2011 | 9:33AM | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:FRX | Forest Road Acquisition Corp |
| 04/19/2011 | 10:22AM | Zacks | Forest Tops Again, Provides Outlook - Analyst Blog | NYSE:FRX | Forest Road Acquisition Corp |
| 04/19/2011 | 9:02AM | Dow Jones News | Forest Labs 4Q Profit Soars Absent Prior-Year Licensing Costs | NYSE:FRX | Forest Road Acquisition Corp |
| 04/19/2011 | 8:30AM | Business Wire | Forest Laboratories & Blue Ash Therapeutics Enter Into Asset Purchase Agreement for Azimilide, a Novel Phase III Antiarrhythm... | NYSE:FRX | Forest Road Acquisition Corp |
| 04/19/2011 | 8:00AM | Business Wire | Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2011 Earnings Per Share of $1.12 | NYSE:FRX | Forest Road Acquisition Corp |
| 04/15/2011 | 8:58AM | Marketwired | Equity Research on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. -- Drug Manufacturers Taking Different Ap | NYSE:FRX | Forest Road Acquisition Corp |